Mode VC
California

TCG Crossover

TCG Crossover is a California-based life sciences specialist that can lead Seed, Series A, and Series B rounds with checks from $10 million to over $30 million.

WebsitePortfolioPitch pageTeam page
Entry stageSeed, Series A, Series B
Check size$10M to $30M+
Leads roundsYes
FocusLife sciences
Latest fund$1.3B (Fund III) (2025)
Investing team8 peopleNo activity since Sep

Who you would pitch at TCG Crossover

8 people on the investing team, 3 of them partners who can make the call. Partners are listed first.

Cariad Chester
Cariad ChesterManaging PartnerHe has led investments in biotechnology and holds a B.A. from Swarthmore College.
Chen Yu
Chen YuManaging PartnerHe has operating experience as COO of Sagent Pharmaceuticals and CBO of China KangHui, and has led investments in numerous companies.
Giuliano Marostica
Giuliano MarosticaManaging PartnerHe holds a BSc in Biomedical Engineering from Brown University and has led investments in several biopharma companies.
Bill Zhang
Bill ZhangAnalystHe holds a BA in Biology from the University of Pennsylvania and completed graduate studies in Bioengineering there.
George Feng
George FengAssociateHe graduated summa cum laude from the University of Pennsylvania with degrees in Bioengineering and Economics.
Haithem Laaribi
Haithem LaaribiAssociateHe holds a B.Sc. in Pharmacology from McGill University.
Michael Albert
Michael AlbertAssociateHe holds a B.A. in Neuroscience from Northwestern University.
Suan Tuang
Suan TuangAssociateHe previously worked at Foresite Capital Management and Eventide Asset Management.

Work here and something is wrong? Ask for a correction.

Writes $10M to $30M+ checks. Its smallest check is larger than 97% of firms in the atlas.

Bars: how many firms in the atlas report each band. Highlighted: this firm.

No recent activity since September 2026. Quiet does not mean closed.

Weekly count of activity updates. Activity is not a confirmed deal.

Before you pitch

Ownership target7-10%
How to reach them[email protected]

In their words

TCGX - Investing in Breakthrough MedicinesTCG Crossover is a science-driven investment firm dedicated to advancing disruptive medicinestcgcrossover.com
Founders and investors at a Mode VC gathering

Send Mode VC your deck

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.

Send your deck

Alert me when TCG Crossover is active

One email when this firm shows new activity. Nothing else.

Firms like TCG Crossover

DCVC$10M to $30M+ · active Oct 8
HealthQuest Capital$10M to $30M+
Samsara BioCapital$10M to $30M
Sofinnova Investments$10M to $30M
Telegraph Hill Partners$10M to $30M
Natural Capital$3M to $30M+

On these lists

Seed life sciences investors in California71Series A life sciences investors in California65Series B life sciences investors in California30Seed investors in United States2836Series A investors in United States1790Seed investors in California699Series B investors in United States563Series A investors in California480

Questions

What stage does TCG Crossover invest in?

TCG Crossover reports entry at seed, series a, series b.

How much does TCG Crossover invest?

TCG Crossover reports checks of $10M to $30M+.

Does TCG Crossover lead rounds?

Yes. TCG Crossover says it can lead.

Who are the partners at TCG Crossover?

Cariad Chester (Managing Partner), Chen Yu (Managing Partner), Giuliano Marostica (Managing Partner).

Is TCG Crossover active right now?

No recent activity since September 2026.

Work at TCG Crossover? Claim or correct this profile.